132 related articles for article (PubMed ID: 27174235)
1. Prognostic and predictive value of serum C-reactive protein levels in patients with metastatic or locally recurrent gastric cancer.
Chen Z; Sun Y; Wang J; Shen X; Chen L; Zhuang Z
Int J Biol Markers; 2016 Jul; 31(3):e294-9. PubMed ID: 27174235
[TBL] [Abstract][Full Text] [Related]
2. Preoperative serum C-reactive protein and gastric cancer; clinical-pathological correlation and prognostic significance.
Chang CC; Sun CF; Pai HJ; Wang WK; Hsieh CC; Kuo LM; Wang CS
Chang Gung Med J; 2010; 33(3):301-12. PubMed ID: 20584508
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic importance of plasma C-reactive protein (CRP) in oncology].
Deme D; Telekes A
Orv Hetil; 2017 Feb; 158(7):243-256. PubMed ID: 28462626
[TBL] [Abstract][Full Text] [Related]
4. Elevated serum C-reactive protein level predicts a poor prognosis for recurrent gastric cancer.
Kong F; Gao F; Chen J; Zheng R; Liu H; Li X; Yang P; Liu G; Jia Y
Oncotarget; 2016 Aug; 7(34):55765-55770. PubMed ID: 27303917
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein is a potential prognostic factor for metastatic gastric cancer.
Shimura T; Kitagawa M; Yamada T; Ebi M; Mizoshita T; Tanida S; Kataoka H; Kamiya T; Joh T
Anticancer Res; 2012 Feb; 32(2):491-6. PubMed ID: 22287736
[TBL] [Abstract][Full Text] [Related]
6. CRP/prealbumin, a novel inflammatory index for predicting recurrence after radical resection in gastric cancer patients: post hoc analysis of a randomized phase III trial.
Lu J; Xu BB; Zheng ZF; Xie JW; Wang JB; Lin JX; Chen QY; Cao LL; Lin M; Tu RH; Huang ZN; Zheng CH; Huang CM; Li P
Gastric Cancer; 2019 May; 22(3):536-545. PubMed ID: 30377862
[TBL] [Abstract][Full Text] [Related]
7. Perioperative CRP: A novel inflammation-based classification in gastric cancer for recurrence and chemotherapy benefit.
Lu J; Xu BB; Xue Z; Xie JW; Zheng CH; Huang CM; Li P
Cancer Med; 2021 Jan; 10(1):34-44. PubMed ID: 33270989
[TBL] [Abstract][Full Text] [Related]
8. Intrahepatic cholangiocarcinoma prognostic determination using pre-operative serum C-reactive protein levels.
Lin ZY; Liang ZX; Zhuang PL; Chen JW; Cao Y; Yan LX; Yun JP; Xie D; Cai MY
BMC Cancer; 2016 Oct; 16(1):792. PubMed ID: 27733196
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Significance of Pre-treatment Serum C-Reactive Protein Level in Patients with Adenocarcinoma of the Uterine Cervix.
Bodner-Adler B; Kimberger O; Schneidinger C; Kölbl H; Bodner K
Anticancer Res; 2016 Sep; 36(9):4691-6. PubMed ID: 27630314
[TBL] [Abstract][Full Text] [Related]
10. Impact of C-reactive protein kinetics on survival of patients with metastatic renal cell carcinoma.
Saito K; Tatokoro M; Fujii Y; Iimura Y; Koga F; Kawakami S; Kihara K
Eur Urol; 2009 May; 55(5):1145-53. PubMed ID: 18930583
[TBL] [Abstract][Full Text] [Related]
11. Serum C-reactive protein: a prognostic factor in metastatic urothelial cancer of the bladder.
Eggers H; Seidel C; Schrader AJ; Lehmann R; Wegener G; Kuczyk MA; Steffens S
Med Oncol; 2013 Dec; 30(4):705. PubMed ID: 24005810
[TBL] [Abstract][Full Text] [Related]
12. C-reactive protein: a biomarker of survival in patients with localized upper tract urothelial carcinoma treated with radical nephroureterectomy.
Obata J; Kikuchi E; Tanaka N; Matsumoto K; Hayakawa N; Ide H; Miyajima A; Nakagawa K; Oya M
Urol Oncol; 2013 Nov; 31(8):1725-30. PubMed ID: 23141922
[TBL] [Abstract][Full Text] [Related]
13. Pretreated baseline neutrophil count and chemotherapy-induced neutropenia may be conveniently available as prognostic biomarkers in advanced gastric cancer.
Chen Z; Chen W; Wang J; Zhu M; Zhuang Z
Intern Med J; 2015 Aug; 45(8):854-9. PubMed ID: 25871806
[TBL] [Abstract][Full Text] [Related]
14. The prognostic role of systemic inflammation in patients undergoing resection of colorectal liver metastases: C-reactive protein (CRP) is a strong negative prognostic biomarker.
Køstner AH; Kersten C; Löwenmark T; Ydsten KA; Peltonen R; Isoniemi H; Haglund C; Gunnarsson U; Isaksson B
J Surg Oncol; 2016 Dec; 114(7):895-899. PubMed ID: 27696432
[TBL] [Abstract][Full Text] [Related]
15. C-reactive protein (CRP) as a prognostic factor for colorectal cancer after surgical resection of pulmonary metastases.
Li C; Xu Q; Chen L; Luo C; Ying J; Liu J
Bull Cancer; 2017 Mar; 104(3):232-236. PubMed ID: 28063672
[TBL] [Abstract][Full Text] [Related]
16. Elevated high-sensitivity C-reactive protein, a marker of advanced stage gastric cancer and postgastrectomy disease recurrence.
Woo Y; Hyung WJ; Obama K; Kim HI; Pak KH; Son T; Noh SH
J Surg Oncol; 2012 Mar; 105(4):405-9. PubMed ID: 22025360
[TBL] [Abstract][Full Text] [Related]
17. Clinical implications of serum C-reactive protein levels in malignant fibrous histiocytoma.
Nakanishi H; Araki N; Kudawara I; Kuratsu S; Matsumine A; Mano M; Naka N; Myoui A; Ueda T; Yoshikawa H
Int J Cancer; 2002 May; 99(2):167-70. PubMed ID: 11979429
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of the serum level of C-reactive protein for the survival of patients with a primary sarcoma of bone.
Nakamura T; Grimer RJ; Gaston CL; Watanuki M; Sudo A; Jeys L
Bone Joint J; 2013 Mar; 95-B(3):411-8. PubMed ID: 23450030
[TBL] [Abstract][Full Text] [Related]
19. Prognostic role of C-reactive protein in gastric cancer: a meta-analysis.
Yu Q; Yu XF; Zhang SD; Wang HH; Wang HY; Teng LS
Asian Pac J Cancer Prev; 2013; 14(10):5735-40. PubMed ID: 24289571
[TBL] [Abstract][Full Text] [Related]
20. Prognostic role of serum concentrations of high-sensitivity C-reactive protein in patients with metastatic colorectal cancer: results from the ITACa trial.
Casadei Gardini A; Carloni S; Scarpi E; Maltoni P; Dorizzi RM; Passardi A; Frassineti GL; Cortesi P; Giannini MB; Marisi G; Amadori D; Lucchesi A
Oncotarget; 2016 Mar; 7(9):10193-202. PubMed ID: 26848624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
